Account
Inquiry
Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only
Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only
Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only
Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only
Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only

Xcel Semaglutide Cagrilintide 5mg Blend Pharmaceutical Grade Peptides for Research Use Only

US$ 5 ~ 10
Min.Order: 1000
Product origin: Hubei
Category: peptides
Product Name: peptides
Availability:In Stock
Product Review : 0 Reviews
Infringement complaint:
* Please contact the supplier via whatsapp first before placing an order
  • Product Name : Xcel Semaglutide and Cagrilintide Blend
  • CAS Number : 1415456-99-3
  • Grade : Pharmaceutical Grade
  • Purity : >99%
  • Appearance : White Lyophilized Powder
  • Sterility : Yes
  • Certification : GMP Certified
  • Primary Application : Weight Management Research
  • Available Specifications : 5mg, 10mg, 15mg, 20mg, 30mg per vial
  • Customization : Available
  • Testing : Third-Party Laboratory Verified
  • Intended Use : Research Applications Only

Xcel semaglutide combined with cagrilintide represents an advanced peptide blend developed for weight management applications. This formulation leverages the synergistic effects of an amylin-analog and a GLP-1 receptor agonist to address complex physiological pathways involved in appetite regulation and metabolic function.

Cagrilintide functions as an amylin-analog that promotes satiety through both homoeostatic and hedonic brain regions. When administered with xcel semaglutide, a potent GLP-1 agonist, the combination demonstrates enhanced appetite suppression through hypothalamic GLP-1 receptors while simultaneously improving insulin secretion and delaying gastric emptying. The complementary mechanisms of these compounds create an additive effect that supports sustained weight management outcomes.

Clinical research indicates that the xcel semaglutide and cagrilintide combination produces significant weight loss results, making it a promising candidate for obesity management strategies. The dual-action approach addresses the heterogeneous nature of obesity pathogenesis through multiple physiological targets.

This pharmaceutical-grade peptide blend is provided as a white lyophilized powder with exceptional purity standards. The product undergoes rigorous quality control testing to ensure batch consistency and performance reliability. All materials are manufactured under GMP conditions suitable for research applications.

Primary research applications include studying gastric emptying mechanisms, liver glucose production regulation, pancreatic insulin secretion patterns, and blood glucose control mechanisms. The compound demonstrates potential for reducing hyperglycemia, improving fasting insulin and glucose levels, and modulating hemoglobin A1c. Additional research applications explore its effects on triglyceride levels, oxidative stress reduction, leptin sensitivity enhancement, and white-to-brown fat conversion processes.

Xcel Semaglutide Cagrilintide BlendPeptide LaboratoryQuality ControlManufacturing ProcessPackaging Standards

This product is supplied exclusively for research purposes and is not intended for human consumption. Researchers must handle all materials according to appropriate laboratory safety protocols and regulatory guidelines.

Add a Review
Home
Account
Order
Categorys